Author： Lee-Dutra Alice Wiener Danielle K Sun Siquan
Publisher： Informa Healthcare
ISSN： 1354-3776
Source： Expert Opinion on Therapeutic Patents, Vol.21, Iss.3, 2011-03, pp. : 311-337
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Inhibitors of cathepsin K: a patent review (2004 – 2010)
Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 10, 2011-10 ,pp. :
Access to resources
Recommend
Cathepsin K inhibitors, 2000 – 2004
By Cai Jiaqiang Jamieson Craig Moir Jennifer Rankovic Zoran
Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 1, 2005-01 ,pp. :
By Leroy Vincent Thurairatnam Sukanthini
Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 3, 2004-03 ,pp. :
Cathepsin S inhibitors: WO2010070615
By Lööser Reik
Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 4, 2011-04 ,pp. :
Carbamate-based reversible inhibitors of cathepsin S and cathepsin K
Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 7, 2003-07 ,pp. :